Sign inGet started

CHYUNG YUNG H.

Insider CIK 1740377 · KROS Chief Medical Officer · SRRK Chief Medical Officer · TRML Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
KROS Keros Therapeutics, Inc. A Award2025-02-182025-02-1944,000— $044,000SEC↗
KROS Keros Therapeutics, Inc. A Award deriv2024-11-082024-11-12110,000— $0110,000SEC↗
TRML Tourmaline Bio, Inc. A Award deriv2023-10-232023-10-2373,211— $073,211SEC↗
TRML Tourmaline Bio, Inc. A Award deriv2023-10-192023-10-23144,215— $0144,215SEC↗
TRML Tourmaline Bio, Inc. A Award2023-10-192023-10-2356,836— $056,836SEC↗
SRRK Scholar Rock Holding Corp A Award deriv2022-02-142022-02-1537,500— $037,500SEC↗
SRRK Scholar Rock Holding Corp A Award2022-02-142022-02-1537,500— $0258,496SEC↗
SRRK Scholar Rock Holding Corp F Tax w/h2022-01-182022-01-191,421$19.46 $27.7K220,996SEC↗
SRRK Scholar Rock Holding Corp A Award deriv2021-02-012021-02-0352,500— $0225,534SEC↗
SRRK Scholar Rock Holding Corp A Award2021-02-012021-02-0315,750— $015,750SEC↗
SRRK Scholar Rock Holding Corp A Award deriv2020-02-062020-02-1075,000— $075,000SEC↗
SRRK Scholar Rock Holding Corp A Award deriv2019-01-312019-02-0456,000— $056,000SEC↗